2010 JP Morgan Healthcare Conference, the Insider Perspective (1/2)
Quick Links
Description
You're Watching:
2010 JP Morgan Healthcare Conference, the Insider Perspective - Part 1
Marina Bozilenko interviews Geoff Meacham, Senior Biotechnology Analyst at JP Morgan. What were the companies that gave the tone, and what was the major news that came out during the week? What are the major milestones that could make or break 2010 for biotech? Have the under-served small cap become a good opportunity?
This interview was conducted at the JP Morgan Conference, on January 13th, 2010, in San Francisco.
Featuring:
- Geoff Meacham, Senior Biotechnology Analyst, JP Morgan
- Marina Bozilenko, Executive Producer, BioBusiness.TV
DISCLAIMER: VIEWERS SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
Related Videos
2010 JP Morgan Healthcare Conference, the Insider Perspective (2/2) ()
<markets>At the end of the 2010 JPM conf, what is the best company-profile for a successful IPO? Is it true that Pharma's validation is no longer sought? Is there a new trend in business models for biotech? What is the take home message of the 2010 conference? An interview of Geoff Meacham of JP Morgan, by Marina Bozilenko.
2010 JP Morgan Healthcare Conference, the Insider Perspective...